First Time Loading...

IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 495.55 USD 1.34% Market Closed
Updated: Apr 27, 2024

Intrinsic Value

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. [ Read More ]

The intrinsic value of one IDXX stock under the Base Case scenario is 246.38 USD. Compared to the current market price of 495.55 USD, IDEXX Laboratories Inc is Overvalued by 50%.

Key Points:
IDXX Intrinsic Value
Base Case
246.38 USD
Overvaluation 50%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
IDEXX Laboratories Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling IDXX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
IDEXX Laboratories Inc

Provide an overview of the primary business activities
of IDEXX Laboratories Inc.

What unique competitive advantages
does IDEXX Laboratories Inc hold over its rivals?

What risks and challenges
does IDEXX Laboratories Inc face in the near future?

Has there been any significant insider trading activity
in IDEXX Laboratories Inc recently?

Summarize the latest earnings call
of IDEXX Laboratories Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for IDEXX Laboratories Inc.

Provide P/S
for IDEXX Laboratories Inc.

Provide P/E
for IDEXX Laboratories Inc.

Provide P/OCF
for IDEXX Laboratories Inc.

Provide P/FCFE
for IDEXX Laboratories Inc.

Provide P/B
for IDEXX Laboratories Inc.

Provide EV/S
for IDEXX Laboratories Inc.

Provide EV/GP
for IDEXX Laboratories Inc.

Provide EV/EBITDA
for IDEXX Laboratories Inc.

Provide EV/EBIT
for IDEXX Laboratories Inc.

Provide EV/OCF
for IDEXX Laboratories Inc.

Provide EV/FCFF
for IDEXX Laboratories Inc.

Provide EV/IC
for IDEXX Laboratories Inc.

Show me price targets
for IDEXX Laboratories Inc made by professional analysts.

What are the Revenue projections
for IDEXX Laboratories Inc?

How accurate were the past Revenue estimates
for IDEXX Laboratories Inc?

What are the Net Income projections
for IDEXX Laboratories Inc?

How accurate were the past Net Income estimates
for IDEXX Laboratories Inc?

What are the EPS projections
for IDEXX Laboratories Inc?

How accurate were the past EPS estimates
for IDEXX Laboratories Inc?

What are the EBIT projections
for IDEXX Laboratories Inc?

How accurate were the past EBIT estimates
for IDEXX Laboratories Inc?

Compare the revenue forecasts
for IDEXX Laboratories Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of IDEXX Laboratories Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of IDEXX Laboratories Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of IDEXX Laboratories Inc compared to its peers.

Compare the P/E ratios
of IDEXX Laboratories Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing IDEXX Laboratories Inc with its peers.

Analyze the financial leverage
of IDEXX Laboratories Inc compared to its main competitors.

Show all profitability ratios
for IDEXX Laboratories Inc.

Provide ROE
for IDEXX Laboratories Inc.

Provide ROA
for IDEXX Laboratories Inc.

Provide ROIC
for IDEXX Laboratories Inc.

Provide ROCE
for IDEXX Laboratories Inc.

Provide Gross Margin
for IDEXX Laboratories Inc.

Provide Operating Margin
for IDEXX Laboratories Inc.

Provide Net Margin
for IDEXX Laboratories Inc.

Provide FCF Margin
for IDEXX Laboratories Inc.

Show all solvency ratios
for IDEXX Laboratories Inc.

Provide D/E Ratio
for IDEXX Laboratories Inc.

Provide D/A Ratio
for IDEXX Laboratories Inc.

Provide Interest Coverage Ratio
for IDEXX Laboratories Inc.

Provide Altman Z-Score Ratio
for IDEXX Laboratories Inc.

Provide Quick Ratio
for IDEXX Laboratories Inc.

Provide Current Ratio
for IDEXX Laboratories Inc.

Provide Cash Ratio
for IDEXX Laboratories Inc.

What is the historical Revenue growth
over the last 5 years for IDEXX Laboratories Inc?

What is the historical Net Income growth
over the last 5 years for IDEXX Laboratories Inc?

What is the current Free Cash Flow
of IDEXX Laboratories Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for IDEXX Laboratories Inc.

Financials

Balance Sheet Decomposition
IDEXX Laboratories Inc

Current Assets 1.5B
Cash & Short-Term Investments 453.9m
Receivables 529.5m
Other Current Assets 511.8m
Non-Current Assets 1.8B
Long-Term Investments 56.2m
PP&E 817.7m
Intangibles 450.5m
Other Non-Current Assets 440.3m
Current Liabilities 951.5m
Accounts Payable 110.6m
Accrued Liabilities 392.2m
Short-Term Debt 250m
Other Current Liabilities 198.7m
Non-Current Liabilities 823.8m
Long-Term Debt 622.9m
Other Non-Current Liabilities 201m
Efficiency

Earnings Waterfall
IDEXX Laboratories Inc

Revenue
3.7B USD
Cost of Revenue
-1.5B USD
Gross Profit
2.2B USD
Operating Expenses
-1.1B USD
Operating Income
1.1B USD
Other Expenses
-253.2m USD
Net Income
845m USD

Free Cash Flow Analysis
IDEXX Laboratories Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

IDXX Profitability Score
Profitability Due Diligence

IDEXX Laboratories Inc's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
75/100
Profitability
Score

IDEXX Laboratories Inc's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

IDXX Solvency Score
Solvency Due Diligence

IDEXX Laboratories Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
78/100
Solvency
Score

IDEXX Laboratories Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IDXX Price Targets Summary
IDEXX Laboratories Inc

Wall Street analysts forecast IDXX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDXX is 616.71 USD with a low forecast of 464.6 USD and a high forecast of 708.75 USD.

Lowest
Price Target
464.6 USD
6% Downside
Average
Price Target
616.71 USD
24% Upside
Highest
Price Target
708.75 USD
43% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

IDXX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

IDXX Price
IDEXX Laboratories Inc

1M 1M
-8%
6M 6M
+27%
1Y 1Y
+2%
3Y 3Y
-11%
5Y 5Y
+115%
10Y 10Y
+699%
Annual Price Range
495.55
52w Low
391.37
52w High
576.87
Price Metrics
Average Annual Return 23.28%
Standard Deviation of Annual Returns 49.83%
Max Drawdown -54%
Shares Statistics
Market Capitalization 41.1B USD
Shares Outstanding 83 933 000
Percentage of Shares Shorted 2.71%

IDXX Return Decomposition
Main factors of price return

What is price return decomposition?

IDXX News

Other Videos

Company Profile

IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc

Country

United States of America

Industry

Health Care

Market Cap

41.1B USD

Dividend Yield

0%

Description

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 10,350 full-time employees. The company also offers human medical point-of-care & laboratory diagnostics. Its products include health monitoring, others. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.

Contact

MAINE
Westbrook
1 Idexx Dr
+12075560300.0
https://www.idexx.com/

IPO

1991-06-21

Employees

10 350

Officers

President, CEO & Director
Mr. Jonathan J. Mazelsky
CFO, Executive VP & Treasurer
Mr. Brian P. McKeon
Executive VP & Chief Commercial Officer
Mr. James F. Polewaczyk
Senior Vice President of Global Operations
Mr. John Hart
Senior Vice President of Commercial Finance & Sales Operations
Mr. Jeffery D. Chadbourne
Senior VP & Chief Information Officer
Mr. Ken Grady
Show More
Executive VP, General Counsel, & Corporate Secretary
Ms. Sharon E. Underberg
Executive VP & Chief Human Resources Officer
Mr. Michael P. Johnson
Senior VP & Chief Revenue Officer
Mr. George J. Fennell
Senior VP and GM of Product & Strategy of Global Reference Labs
Ms. Kerry Bennett
Show Less

See Also

Discover More
What is the Intrinsic Value of one IDXX stock?

The intrinsic value of one IDXX stock under the Base Case scenario is 246.38 USD.

Is IDXX stock undervalued or overvalued?

Compared to the current market price of 495.55 USD, IDEXX Laboratories Inc is Overvalued by 50%.